Müller R - Search Results

1

Modulation of actin dynamics as potential macrophage subtype-targeting anti-tumour strategy.

Pergola C, Schubert K, Pace S, Ziereisen J, Nikels F, Scherer O, Hüttel S, Zahler S, Vollmar AM, Weinigel C, Rummler S, Müller R, Raasch M, Mosig A, Koeberle A, Werz O. Pergola C, et al. Among authors: muller r. Sci Rep. 2017 Jan 30;7:41434. doi: 10.1038/srep41434. Sci Rep. 2017. PMID: 28134280 Free PMC article.

2

Methods to optimize myxobacterial fermentations using off-gas analysis.

Hüttel S, Müller R. Hüttel S, et al. Among authors: muller r. Microb Cell Fact. 2012 May 9;11:59. doi: 10.1186/1475-2859-11-59. Microb Cell Fact. 2012. PMID: 22571441 Free PMC article.

3

Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.

Rath S, Liebl J, Fürst R, Ullrich A, Burkhart JL, Kazmaier U, Herrmann J, Müller R, Günther M, Schreiner L, Wagner E, Vollmar AM, Zahler S. Rath S, et al. Among authors: muller r. Br J Pharmacol. 2012 Nov;167(5):1048-61. doi: 10.1111/j.1476-5381.2012.02037.x. Br J Pharmacol. 2012. PMID: 22595030 Free PMC article.

4

Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.

Herrmann J, Elnakady YA, Wiedmann RM, Ullrich A, Rohde M, Kazmaier U, Vollmar AM, Müller R. Herrmann J, et al. Among authors: muller r. PLoS One. 2012;7(5):e37416. doi: 10.1371/journal.pone.0037416. Epub 2012 May 17. PLoS One. 2012. PMID: 22616003 Free PMC article.

5

Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus "Aetherobacter".

Plaza A, Garcia R, Bifulco G, Martinez JP, Hüttel S, Sasse F, Meyerhans A, Stadler M, Müller R. Plaza A, et al. Among authors: muller r. Org Lett. 2012 Jun 1;14(11):2854-7. doi: 10.1021/ol3011002. Epub 2012 May 22. Org Lett. 2012. PMID: 22616796

6

The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1.

Wiedmann RM, von Schwarzenberg K, Palamidessi A, Schreiner L, Kubisch R, Liebl J, Schempp C, Trauner D, Vereb G, Zahler S, Wagner E, Müller R, Scita G, Vollmar AM. Wiedmann RM, et al. Among authors: muller r. Cancer Res. 2012 Nov 15;72(22):5976-87. doi: 10.1158/0008-5472.CAN-12-1772. Epub 2012 Sep 17. Cancer Res. 2012. PMID: 22986742

7

Discovery and biological activity of new chondramides from Chondromyces sp.

Herrmann J, Hüttel S, Müller R. Herrmann J, et al. Among authors: muller r. Chembiochem. 2013 Sep 2;14(13):1573-80. doi: 10.1002/cbic.201300140. Epub 2013 Aug 19. Chembiochem. 2013. PMID: 23959765

8

V-ATPase inhibition overcomes trastuzumab resistance in breast cancer.

von Schwarzenberg K, Lajtos T, Simon L, Müller R, Vereb G, Vollmar AM. von Schwarzenberg K, et al. Among authors: muller r. Mol Oncol. 2014 Feb;8(1):9-19. doi: 10.1016/j.molonc.2013.08.011. Epub 2013 Sep 5. Mol Oncol. 2014. PMID: 24055142 Free PMC article.

9

Simplified pretubulysin derivatives and their biological effects on cancer cells.

Kubisch R, von Gamm M, Braig S, Ullrich A, Burkhart JL, Colling L, Hermann J, Scherer O, Müller R, Werz O, Kazmaier U, Vollmar AM. Kubisch R, et al. Among authors: muller r. J Nat Prod. 2014 Mar 28;77(3):536-42. doi: 10.1021/np4008014. Epub 2014 Jan 17. J Nat Prod. 2014. PMID: 24437936

10

V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.

Schempp CM, von Schwarzenberg K, Schreiner L, Kubisch R, Müller R, Wagner E, Vollmar AM. Schempp CM, et al. Among authors: muller r. Mol Cancer Ther. 2014 Apr;13(4):926-37. doi: 10.1158/1535-7163.MCT-13-0484. Epub 2014 Jan 30. Mol Cancer Ther. 2014. PMID: 24482380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,478 results

Search Page

Filters